Precision Medicine in Control of Visceral Leishmaniasis Caused by L. donovani
Precision medicine and precision global health in visceral leishmaniasis (VL) have not yet been described and could take into account how all known determinants improve diagnostics and treatment for the individual patient. Precision public health would lead to the right intervention in each VL endem...
Guardado en:
Autor principal: | Eduard E. Zijlstra |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/379b6f9beb104eb79b65e6f37d4d87fc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Visceral leishmaniasis and HIV coinfection: current perspectives
por: Lindoso JAL, et al.
Publicado: (2018) -
Hepatomegaly Associated with Non-Obstructive Sinusoidal Dilation in Experimental Visceral Leishmaniasis
por: Kota Maeda, et al.
Publicado: (2021) -
Pediatric visceral leishmaniasis in Tartous, Syria
por: Ali Othman Hamwi, et al.
Publicado: (2020) -
Magnitude of visceral leishmaniasis and poor treatment outcome among HIV patients: meta-analysis and systematic review
por: Alemayehu M, et al.
Publicado: (2016) -
Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis
por: Want MY, et al.
Publicado: (2017)